Clinical Trial Update: Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating albumin-bound paclitaxel plus gemcitabine as first-line therapy for inoperable pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Pancreatic Cancer | Phase 4 | Status: RECRUITING